Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTaysha Gene Therapies, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2026 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2026 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2026 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
Taysha Gene Therapies, Inc. Earnings Date And Information
Taysha Gene Therapies, Inc. last posted its earnings results on Wednesday, February 26th, 2025. The company reported $-0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.01. The company had revenue of 2.02 M for the quarter and had revenue of 8.33 M for the year. Taysha Gene Therapies, Inc. has generated $0 earnings per share over the last year ($-0.36 diluted earnings per share) and currently has a price-to-earnings ratio of -4.87. Taysha Gene Therapies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Taysha Gene Therapies, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/26/2025 | Q4 2024 | -$0.08 | -$0.07 | 0.01 | $2.14 M | $2.02 M |
| 11/13/2024 | Q3 2024 | -$0.08 | -$0.10 | -0.02 | $1.74 M | $1.79 M |
| 08/12/2024 | Q2 2024 | -$0.10 | -$0.09 | 0.01 | $2.76 M | $1.11 M |
| 05/14/2024 | Q1 2024 | -$0.11 | -$0.10 | 0.01 | N/A | $3.41 M |
| 03/19/2024 | Q4 2023 | -$0.09 | $0.26 | 0.35 | $2.95 M | $3.60 M |
| 11/14/2023 | Q3 2023 | -$0.13 | -$0.93 | -0.8 | $2.33 M | $4.75 M |
| 08/14/2023 | Q2 2023 | -$0.31 | -$0.38 | -0.07 | $2.40 M | $2.40 M |
| 05/11/2023 | Q1 2023 | -$0.35 | -$0.32 | 0.03 | N/A | $4.71 M |
| 04/27/2023 | Q4 2022 | N/A | -$1.03 | N/A | N/A | $2.50 M |
| 11/08/2022 | Q3 2022 | -$0.89 | -$0.67 | 0.22 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$1.05 | -$0.87 | 0.18 | N/A | $0 |
| 05/16/2022 | Q1 2022 | -$1.04 | -$1.33 | -0.29 | N/A | $0 |
| 03/31/2022 | Q4 2021 | -$1.21 | -$1.32 | -0.11 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$1.02 | -$1.35 | -0.33 | N/A | $0 |
| 08/16/2021 | Q2 2021 | -$0.81 | -$1.09 | -0.28 | N/A | $0 |
| 05/11/2021 | Q1 2021 | -$0.54 | -$0.87 | -0.33 | N/A | $0 |
| 03/03/2021 | Q4 2020 | -$0.37 | -$1.04 | -0.67 | N/A | $0 |
| 11/12/2020 | Q3 2020 | -$0.17 | -$1.28 | -1.11 | N/A | $0 |
| 06/30/2020 | Q2 2020 | N/A | -$0.61 | N/A | N/A | $0 |
| 03/31/2020 | Q1 2020 | N/A | -$0.36 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Taysha Gene Therapies, Inc. Earnings: FAQ's
Taysha Gene Therapies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based offlast year's report dates.
In the previous quarter, Taysha Gene Therapies, Inc. (:TSHA) reported $-0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.01.
The conference call for Taysha Gene Therapies, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Taysha Gene Therapies, Inc.'s latest earnings report can be read online.
Taysha Gene Therapies, Inc. (:TSHA) has a recorded annual revenue of $8.33 M.
Taysha Gene Therapies, Inc. (:TSHA) has a recorded net income of $-89,298,000.Taysha Gene Therapies, Inc. has generated $-0.36 earnings per share over the last four quarters.
Taysha Gene Therapies, Inc. (:TSHA) has a price-to-earnings ratio of -4.87 and price/earnings-to-growth ratio is 0.